2025
SJR Q1
JCR Q1 · 5,2
OA
76 eşleşen makale
SCIE
Dergi ayrıntısı
Breast
- Yayıncı
- Churchill Livingstone
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0960977615323080
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 2,654
- Quartile Q1
- H-Index 111
- Atıf/yayın 4,84
- Doküman (3y) 425
- Atıf (3y) 3.612
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 6,8
- JCI 2,08
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cancer Research Q1
- Medicine (miscellaneous) Q1
- Oncology Q1
- Surgery Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Oncology | Obstetrics & Gynecology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,654 | 5,2 | 6,8 | 2,08 | Q1 | 111 |
| 2024 | Q1 | Q1 | 2,348 | 7,9 | 5,5 | 1,82 | Q1 | 106 |
| 2023 | Q1 | Q1 | 1,688 | 5,7 | 4,7 | 1,55 | Q1 | 106 |
| 2022 | Q1 | Q1 | 1,269 | 3,9 | 4,1 | 1,12 | Q1 | 106 |
| 2021 | Q1 | Q1 | 1,162 | 4,3 | 4,5 | 1,21 | Q1 | 106 |
| 2020 | Q1 | Q1 | 1,563 | 4,4 | 4,3 | 1,23 | Q1 | 106 |
| 2019 | Q1 | Q1 | 1,403 | 3,8 | 3,5 | 1,25 | Q1 | 106 |
| 2018 | — | Q1 | — | 3,5 | 3,2 | 1,19 | Q1 | — |
| 2017 | Q1 | Q1 | 1,339 | 3 | 3 | 1,01 | Q2 | 106 |
| 2016 | Q1 | Q1 | 1,352 | 2,8 | 2,8 | — | — | 106 |
| 2015 | Q1 | Q1 | 1,347 | 2,7 | 2,7 | — | — | 106 |
| 2014 | Q1 | Q2 | 1,13 | 2,4 | 2,2 | — | — | 106 |
| 2013 | Q1 | Q1 | 1,132 | 2,6 | 2,3 | — | — | 106 |
| 2012 | Q1 | Q2 | 0,942 | 2 | 2,2 | — | — | 106 |
| 2011 | Q1 | Q1 | 0,943 | 2,5 | 2,2 | — | — | 106 |
| 2010 | Q1 | Q2 | 0,887 | 2,1 | 2,1 | — | — | 106 |
| 2009 | — | Q2 | — | 2,1 | 2 | — | — | — |
| 2008 | — | Q2 | — | 2,2 | 2,3 | — | — | — |
| 2006 | — | Q2 | — | 1,7 | — | — | — | — |
| 2005 | — | Q2 | — | 1,7 | — | — | — | — |
| 2004 | — | Q3 | — | 0,8 | — | — | — | — |
| 2003 | — | Q4 | — | 0,5 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q3 | — | 0,6 | — | — | — | — |
| 1999 | — | Q2 | — | 0,8 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,6 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 9/143 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 81/333 |
| 2024 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 4/141 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 40/328 |
| 2023 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 8/136 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 54/322 |
| 2022 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 20/85 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q1 | 103/241 |
| 2021 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 20/85 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q1 | 123/245 |
| 2020 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 11/83 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q1 | 114/242 |
| 2019 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 10/82 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q1 | 98/244 |
| 2018 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q1 | 10/83 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q1 | 89/230 |
| 2017 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q2 | 15/82 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q2 | 126/223 |
| 2016 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | — | 18/80 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 119/217 |
| 2015 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | — | 17/80 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 116/213 |
| 2014 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 21/79 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 129/211 |
| 2013 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | — | 17/78 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 111/203 |
| 2012 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 28/78 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 129/197 |
| 2011 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | — | 16/79 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 103/196 |
| 2010 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 22/77 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 113/185 |
| 2009 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 23/70 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 100/166 |
| 2008 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 20/61 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 96/143 |
| 2006 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 27/59 |
| 2006 | ONCOLOGY | SCIE | Q3 | — | 94/127 |
| 2005 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 23/57 |
| 2005 | ONCOLOGY | SCIE | Q3 | — | 84/123 |
| 2004 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 41/55 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 111/123 |
| 2003 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 50/53 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 114/120 |
| 2002 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 47/52 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 105/114 |
| 2001 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 45/52 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 96/107 |
| 2000 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 41/57 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 94/103 |
| 1999 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 28/56 |
| 1999 | ONCOLOGY | SCIE | Q4 | — | 81/105 |
| 1998 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 31/53 |
| 1998 | ONCOLOGY | SCIE | Q3 | — | 77/104 |
| 1997 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 33/54 |
| 1997 | ONCOLOGY | SCIE | Q4 | — | 77/102 |